Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bentong ginger oleoresin is an extract derived from *Zingiber officinale Roscoe* var. Bentong, a ginger cultivar exclusive to Bentong, Malaysia. This oleoresin is particularly rich in bioactive compounds such as **6-gingerol** and **6-shogaol**, contributing to its potent **antioxidant**, **anti-inflammatory**, and **antihypercholesterolemic** activities[3][5][7]. Studies show Bentong ginger oleoresin can mitigate liver injury, regulate gut microbiota, and improve abnormal lipid metabolism, especially in nonalcoholic fatty liver disease (NAFLD) models[3]. Its mechanisms include the mediation of the NF-κB signaling pathway, reduction of inflammatory cytokines, and inhibition of oxidative stress[3][5]. The substance is widely used as a functional food ingredient and dietary supplement.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bentong ginger oleoresin.